Redmile Group and Sofinnova Partners led a $15m funding in Home Biosciences.

Redmile Group, a hedge fund and private equity manager, and Sofinnova Partners, a venture capital firm, led a $15m funding in Home Biosciences, a venture builder dedicated to biotech. “Home Biosciences is pioneering an innovative model that fills an important gap in the European biotech ecosystem. We are delighted to join forces with Redmile Group in supporting Europe’s first biotech venture builder in its mission to provide financial support and operational guidance, to create the groundbreaking therapies of the future," Antoine Papiernik, Sofinnova Partners Managing Partner.